Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published ...

The treatment reduced the risk of hospitalization by 83% U.S. babies enjoyed better protection because treatment was prioritized for high-risk infants TUESDAY, May 6, 2025 (HealthDay News ...

Recent data shows that most infants are receiving RSV vaccination in the US, but rates vary by race and birth month.

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

Saskatchewan is expanding its infant immunization program to protect all newborns from Respiratory Syncytial Virus (RSV) ...

The U.S. Centers for Disease Control and Prevention (CDC) recommends that all babies be protected from RSV by one of two ...

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment ...

A recent study revealed that newborns can be easily protected against respiratory syncytial virus infection by using the ...

Babies treated with nirsevimab had an 83% reduced risk of hospitalization due to RSV infection, researchers reported May 1 in The Lancet Child & Adolescent Health. The antibody treatment also ...